Morpholino

MO1-egfra

ID

ZDB-MRPHLNO-150730-5

Name

MO1-egfra

Previous Names

None

Target

Sequence

5' - AGCTCTCGGGCTTCACTCCATACTT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO. Targets the 5'UTR.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-egfra

Phenotype

Phenotype resulting from MO1-egfra

Phenotype	Fish	Figures
caudal fin runx1 expression decreased amount, abnormal	WT + MO1-egfra	Fig. 4 from Grainger et al., 2019
caudal fin gata2b expression decreased amount, abnormal	WT + MO1-egfra	Fig. 4 from Grainger et al., 2019
dorsal aorta decreased diameter, abnormal	zn1Tg + MO1-egfra	Fig. S9 from Zhao et al., 2013
dorsal aorta blood vessel lumenization decreased process quality, abnormal	zn1Tg + MO1-egfra	Fig. S9 from Zhao et al., 2013
trunk gata2b expression decreased amount, abnormal	WT + MO1-egfra	Fig. 4 from Grainger et al., 2019
trunk runx1 expression decreased amount, abnormal	WT + MO1-egfra	Fig. 4 from Grainger et al., 2019

Phenotype of all Fish created by or utilizing MO1-egfra

Phenotype	Fish	Conditions	Figures
caudal fin gata2b expression decreased amount, abnormal	WT + MO1-egfra	standard conditions	Fig. 4 from Grainger et al., 2019
caudal fin runx1 expression decreased amount, abnormal	WT + MO1-egfra	standard conditions	Fig. 4 from Grainger et al., 2019
trunk runx1 expression decreased amount, abnormal	WT + MO1-egfra	standard conditions	Fig. 4 from Grainger et al., 2019
trunk gata2b expression decreased amount, abnormal	WT + MO1-egfra	standard conditions	Fig. 4 from Grainger et al., 2019
dorsal aorta decreased diameter, abnormal	zn1Tg + MO1-egfra	standard conditions	Fig. S9 from Zhao et al., 2013
dorsal aorta blood vessel lumenization decreased process quality, abnormal	zn1Tg + MO1-egfra	standard conditions	Fig. S9 from Zhao et al., 2013
ventral aorta myb expression decreased amount, abnormal	WT + MO1-egfra + MO1-wnt9a	standard conditions	Fig. 4 from Grainger et al., 2019
ventral aorta myb expression decreased amount, abnormal	WT + MO1-egfra + MO2-fzd9b	standard conditions	Fig. 4 from Grainger et al., 2019
dorsal aorta decreased diameter, abnormal	zn1Tg + MO1-egfra + MO1-sh3gl3b	standard conditions	Fig. S9 from Zhao et al., 2013
dorsal aorta blood vessel lumenization decreased process quality, abnormal	zn1Tg + MO1-egfra + MO1-sh3gl3b	standard conditions	Fig. S9 from Zhao et al., 2013

Citations